Cancer Family
Thoracic Neoplasm
CI-CAN-00000054Explore in graph →
Non-malignant2,893 active trials51 approved drugs626 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000054Explore in graph →
Clinical trials
12,167 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04013334 | MTG201 Plus Nivolumab in Patients With Relapsed Pleural Mesothelioma | unknown | Phase 2 | 12 | Momotaro-Gene Inc.INDUSTRY | 1 | Jun 16, 2022 | clinicaltrials |
| NCT05417672 | Assessment of Relationship Between Preoperative Nutritional Status and Perioperative/Postoperative Conditions in Patients With Lung Cancer Scheduled for Lobectomy | unknown | — | 63 | Turkish Society of Anesthesiology and ReanimationOTHER | 1 | Jun 14, 2022 |
| clinicaltrials |
| NCT05414188 | Beneficial Effect of Pulmonary Rehabilitation in Lung Cancer Patients Receiving Radiation Therapy | unknown | N/A | 70 | Asan Medical CenterOTHER | 1 | Jun 10, 2022 | clinicaltrials |
| NCT05414630 | A Study of Envafolimab in Subjects With Stage III Non-Small Cell Lung Cancer | unknown | Phase 2 | 30 | Anhui Provincial Cancer HospitalOTHER | 1 | Jun 10, 2022 | clinicaltrials |
| NCT05411276 | A Real-World Study of Pyrotinib Maleate in the Treatment of Advanced/Metastatic Non-Small Cell Lung Cancer With Rare Mutations in HER2 | unknown | — | 15 | Beijing Chest HospitalOTHER | 0 | Jun 9, 2022 | clinicaltrials |
| NCT05407649 | Abscopal Effect of Radiotherapy in Combination With rhGM-CSF for Advanced Thymic Epithelial Tumours | unknown | Phase 2 | 60 | Shanghai Cancer Hospital, ChinaOTHER | 1 | Jun 7, 2022 | clinicaltrials |
| NCT03975504 | China Lung Cancer Screening (CLUS) Study Version 2.0 | unknown | N/A | 6,000 | Shanghai Chest HospitalOTHER | 1 | Jun 1, 2022 | clinicaltrials |
| NCT05331391 | A Mobile SMART Exercise Support Program to Improve Fatigue in Lung Cancer Patients - A RCT | unknown | N/A | 120 | The University of Hong KongOTHER | 1 | Jun 1, 2022 | clinicaltrials |
| NCT05394233 | Tislelizumab +Bevacizumab+pc for Untreated EGFR+ and High PD-L1 Non-squamous NSCLC | unknown | Phase 2 | 20 | Sichuan Cancer Hospital and Research InstituteOTHER | 1 | May 27, 2022 | clinicaltrials |
| NCT05395611 | Exhaled Breath Particles in Lung Cancer | unknown | — | 300 | Lund University HospitalOTHER | 1 | May 27, 2022 | clinicaltrials |
| NCT04029155 | Conventional vs Ultrathin Bronchoscopy for Peripheral Pulmonary Lesions | unknown | N/A | 142 | Stefano GaspariniOTHER | 0 | May 26, 2022 | clinicaltrials |
| NCT05110950 | Endobronchial Ultrasound Needle Aspiration With and Without Suction | unknown | N/A | 306 | Università Politecnica delle MarcheOTHER | 1 | May 26, 2022 | clinicaltrials |
| NCT05392686 | PD1 and PARP for Maintenance Therapy in NSLLC | unknown | Phase 2 | 52 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | May 26, 2022 | clinicaltrials |
| NCT05262582 | Comparison of Single Port and Two Ports Robotic Assisted Thoracic Surgery for Thymectomy(RATS) | unknown | N/A | 60 | Shanghai Pulmonary Hospital, Shanghai, ChinaOTHER | 1 | May 24, 2022 | clinicaltrials |
| NCT05387044 | SBRT for Oligoprogressive NSCLC After First Line Treatment With Immune Checkpoint Inhibitors | unknown | Phase 2 | 28 | Zhejiang Cancer HospitalOTHER | 1 | May 24, 2022 | clinicaltrials |
| NCT05387109 | Penpulimab Combined With Anlotinib in Neoadjuvant Treatment of Resectable Non-small Cell Lung Cancer(pcwaintrl) | unknown | Phase 4 | 41 | Tang-Du HospitalOTHER | 0 | May 24, 2022 | clinicaltrials |
| NCT05085054 | Salvage Surgery Following Downstaging of Advanced Non-small Cell Lung Cancer by Targeted Therapy (SDANT) | unknown | Phase 2 | 30 | Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyOTHER | 0 | May 20, 2022 | clinicaltrials |
| NCT05319886 | Observational Study of the Efficacy and Safety of Anlotinib Combined With Penpulimab in Elderly Lung Cancer Patients(AP) | unknown | — | 40 | The First Affiliated Hospital of Xinxiang Medical CollegeOTHER | 1 | May 20, 2022 | clinicaltrials |
| NCT05377788 | Lazertinib Real-world Observational Study of in Pre-treated EGFR T790M Mutant With Advanced Non-small Cell Lung Cancer | unknown | — | 900 | Samsung Medical CenterOTHER | 1 | May 19, 2022 | clinicaltrials |
| NCT05380999 | The Red Blood Cells Based Blood Test for Lung Cancer EARLY Detection | unknown | — | 852 | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical SchoolOTHER | 0 | May 19, 2022 | clinicaltrials |
| NCT05380271 | Efficacy and Safety of DEB-BACE With Sequential Arotinib and Tirelizumab in the Treatment of Advanced NSCLC | unknown | Phase 2 | 60 | Gang WuOTHER | 0 | May 18, 2022 | clinicaltrials |
| NCT04052412 | Biodistribution and Kinetics of 18F-AraG in Non-Small Cell Lung Cancer | unknown | Phase 1 | 2 | University of TennesseeOTHER | 1 | May 13, 2022 | clinicaltrials |
| NCT04235556 | Integrated Care Pathway in Oncology (PASSION)(PASSION) | unknown | — | 1,800 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | May 13, 2022 | clinicaltrials |
| NCT03521986 | Pain and Quality of Life After Mediastinal Tumor Resection by Subxiphoid and Intercostal VATS | unknown | Phase 3 | 100 | Lei JiangOTHER | 1 | May 11, 2022 | clinicaltrials |
| NCT04346914 | Study of ZKAB001 Combined With Carboplatin and Etoposide in the Extensive Small Cell Lung Cancer | unknown | Phase 1 | 20 | Lee's Pharmaceutical LimitedINDUSTRY | 1 | May 11, 2022 | clinicaltrials |
| NCT04963972 | Digital and Behavioral Tele-Health Tapering Program for Lowering Dependence on Opioids in Patients Undergoing Surgery | unknown | N/A | 272 | Lucid Lane, IncINDUSTRY | 1 | May 10, 2022 | clinicaltrials |
| NCT03606239 | NSCLC Isotoxic Hypofractionated Chemoradiotherapy(IHRC) | unknown | N/A | 30 | The Second Hospital of Hebei Medical UniversityOTHER | 1 | May 9, 2022 | clinicaltrials |
| NCT03606291 | NSCLC Isotoxic Hypofractionated Radiotherapy(IHR) | unknown | N/A | 30 | The Second Hospital of Hebei Medical UniversityOTHER | 1 | May 9, 2022 | clinicaltrials |
| NCT04009915 | VATS VS. Open Thoracic Surgery for Stage II - III Lung Cancer(VOLCANO) | unknown | Phase 3 | 200 | Shanghai Pulmonary Hospital, Shanghai, ChinaOTHER | 1 | May 9, 2022 | clinicaltrials |
| NCT01585545 | Radiomic Assessment in NSCLC: Correlation Between Multiparametric Imaging Biomarkers and Genetic Biomarkers | unknown | — | 500 | Samsung Medical CenterOTHER | 1 | May 5, 2022 | clinicaltrials |
| NCT05354700 | A Clinical Study to Evaluate the Efficacy and Safety of HLX07 Combination Therapy in Patients With Extensive Small Cell Lung Cancer | unknown | Phase 2 | 20 | Shanghai Henlius BiotechINDUSTRY | 1 | May 4, 2022 | clinicaltrials |
| NCT05360979 | A Clinical Study of Immunotherapy Combined With Chemotherapy and Anti-angiogenic Therapy in Operable NSCLC | unknown | Phase 2 | 42 | Second Xiangya Hospital of Central South UniversityOTHER | 1 | May 4, 2022 | clinicaltrials |
| NCT05154474 | Assessment of Sarcopenia at Diagnosis for Patients With Previously Untreated Metastatic Cancer or Hematologic Malignancy(SPACE2) | unknown | — | 150 | WepromOTHER | 1 | May 3, 2022 | clinicaltrials |
| NCT05358041 | Cone Beam CT Guided Robotic Navigational Bronchoscopy(CBCTRNB) | unknown | — | 200 | Columbus Regional HealthOTHER | 1 | May 3, 2022 | clinicaltrials |
| NCT02562963 | Clinical Efficacy and Safety of NKT Cell Infusion in Patients With Advanced Solid Tumor | unknown | Phase 1 / Phase 2 | 120 | Minghui ZhangOTHER | 1 | May 2, 2022 | clinicaltrials |
| NCT04878107 | SBRT/LDRT in Combination With Camrelizumab and Apatinib in Metastatic Non-small Cell Lung Cancer Patient Previously Treated With PD-1/L1 Inhibitor and Chemotherapy(SABRE) | unknown | Phase 2 | 88 | Wuhan UniversityOTHER | 1 | May 2, 2022 | clinicaltrials |
| NCT05162196 | The Efficacy and Safety of Radiotherapy Plus Niraparib and Toripalimab in Patients With Recurrent Small Cell Lung Cancer | unknown | Phase 2 | 57 | Wuhan UniversityOTHER | 0 | May 2, 2022 | clinicaltrials |
| NCT03563482 | Correlation of Metabolic Imaging With Immune Markers in NSCLC Candidate to Immunotherapy. | unknown | N/A | 500 | Istituto Clinico HumanitasOTHER | 1 | Apr 28, 2022 | clinicaltrials |
| NCT05351320 | WX-0593 Combined With Concurrent Chemoradiotherapy in Unresectable Locally Advanced NSCLC | unknown | Phase 2 | 40 | Jinming YuOTHER | 1 | Apr 28, 2022 | clinicaltrials |
| NCT05063396 | OFA in Thoracic Surgery | unknown | N/A | 60 | Shanghai Zhongshan HospitalOTHER | 1 | Apr 27, 2022 | clinicaltrials |
| NCT03997799 | Comparison of Two Techniques of Uniportal VATS Lobectomies for Clinical Stage I Non-Small Cell Lung Cancer | unknown | N/A | 20 | Pulmonary Hospital ZakopaneOTHER | 1 | Apr 26, 2022 | clinicaltrials |
| NCT04743752 | Obstructive Sleep Apnea Influences Efficacy of PD-1-Based Immunotherapy Against Non-Small Cell Lung Cancer | unknown | — | 200 | Peking University First HospitalOTHER | 1 | Apr 26, 2022 | clinicaltrials |
| NCT05346952 | A Study of TQB2450 Injection Plus Chemotherapy Followed by TQB2450 Plus Anlotinib Versus Tislelizumab Plus Chemotherapy Followed by Tislelizumab in the Treatment of First-line Non-squamous Non-small Cell Lung Cancer(NSCLC). | unknown | Phase 3 | 390 | Chia Tai Tianqing Pharmaceutical Group Co., Ltd.INDUSTRY | 1 | Apr 26, 2022 | clinicaltrials |
| NCT03679936 | Diagnostic Significance of Single Center, Open and Prospective Evaluation of <Sup>18<Sup>F-FDG PET/CT Dynamic Imaging and Genomic Sequencing in Detecting Metastatic Lesions and Differentiating Multiple Primary Lung Cancer From Intrapulmonary Metastases of Non-small Cell Lung Cancer | unknown | — | 120 | Fifth Affiliated Hospital, Sun Yat-Sen UniversityOTHER | 1 | Apr 25, 2022 | clinicaltrials |
| NCT04948047 | Breath Combined With CT for Diagnoses of Pulmonary Nodules | unknown | — | 900 | Peking University People's HospitalOTHER | 1 | Apr 20, 2022 | clinicaltrials |
| NCT05326425 | Lazertinib in Patients With NSCLC With Asymptomatic or Mild Symptomatic Brain Metastases After Failure of EGFR TKI. | unknown | Phase 2 | 40 | Jin Hyoung KangOTHER | 1 | Apr 20, 2022 | clinicaltrials |
| NCT03711305 | Study of Carboplatin Plus Etoposide With or Without SHR-1316 in Participants With Untreated Extensive-Stage (ES) Small Cell Lung Cancer (SCLC) | unknown | Phase 3 | 462 | Jiangsu HengRui Medicine Co., Ltd.INDUSTRY | 1 | Apr 18, 2022 | clinicaltrials |
| NCT05332171 | Examination Of Exercise Adherence İn Lung Cancer Patients Given Calisthenic Exercise | unknown | N/A | 30 | Hasan Kalyoncu UniversityOTHER | 1 | Apr 18, 2022 | clinicaltrials |
| NCT04759651 | Sleep Disorders in Patients With Suspected Lung Cancer Before and After Thoracic Surgery | unknown | — | 1,200 | Koç UniversityOTHER | 1 | Apr 15, 2022 | clinicaltrials |
Data updated 24 days agoSource updated Jun 16, 2022source: clinicaltrials